Respiratory Infections & Comorbidities
This track focuses on the prevention, diagnosis, and management of respiratory infections and their impact on chronic lung diseases such as COPD and asthma. It highlights common infections, exacerbation triggers, antimicrobial resistance, and vaccination strategies, along with the role of comorbid conditions like cardiovascular disease, diabetes, and osteoporosis in disease progression. The session emphasizes integrated care approaches, early intervention, and multidisciplinary management to reduce complications, hospitalizations, and improve overall respiratory health outcomes.
COPD & Cardio-Metabolic Health
This track focuses on the complex interplay between COPD and common cardiovascular and metabolic conditions such as hypertension, coronary artery disease, diabetes, and metabolic syndrome. It explores shared risk factors, underlying inflammatory mechanisms, and the impact of comorbidities on disease progression, treatment outcomes, and mortality. Sessions will highlight integrated care approaches, multidisciplinary management strategies, and evidence-based interventions to improve overall patient outcomes and quality of life.
Allied Health in Respiratory Care
This track highlights the essential role of allied health professionals in the comprehensive management of respiratory diseases, including COPD and other chronic lung conditions. It focuses on respiratory therapy, pulmonary rehabilitation, physiotherapy, occupational therapy, nutrition support, and patient education aimed at improving breathing function, exercise tolerance, and quality of life. Emphasis is placed on multidisciplinary teamwork, evidence-based interventions, home-based care, and long-term disease self-management to enhance patient outcomes across clinical and community settings.
Quality of Life in Lung Health
This track focuses on improving the physical, emotional, and social well-being of individuals living with chronic lung diseases. It highlights symptom control, patient education, self-management strategies, pulmonary rehabilitation, and psychosocial support aimed at enhancing daily functioning and long-term quality of life.
Advances in COPD Pharmacotherapy
This track highlights the latest developments in pharmacological treatments for COPD, focusing on novel bronchodilators, combination inhaler therapies, anti-inflammatory agents, and biologics. It covers personalized treatment strategies, optimizing drug delivery, managing exacerbations, and improving symptom control and long-term outcomes through evidence-based medication approaches.
AI-Driven Respiratory Care
This track explores how artificial intelligence and digital technologies are transforming respiratory care and pulmonology. It highlights AI-based diagnostic tools, predictive analytics for disease progression and exacerbations, smart spirometry, imaging analysis, and remote patient monitoring for conditions such as COPD and asthma. The session also covers clinical decision support systems, tele-pulmonology, personalized treatment planning, and the integration of AI into routine respiratory practice to improve accuracy, efficiency, and patient outcomes.
Next-Gen COPD Treatments
This track explores emerging and future-focused therapeutic strategies transforming the management of chronic obstructive pulmonary disease (COPD). It highlights novel pharmacological agents, precision inhaler technologies, biologics, and anti-inflammatory therapies aimed at improving symptom control and slowing disease progression. Sessions will also cover advances in regenerative medicine, stem cell research, gene-based approaches, and targeted molecular therapies. Ongoing and upcoming clinical trials, real-world evidence, and personalized treatment strategies based on disease phenotypes and biomarkers will be discussed. The track emphasizes innovation, translational research, and the path from clinical trials to routine COPD care.
Personalized Respiratory Medicine
This track focuses on precision and personalized approaches to respiratory care, particularly in COPD and chronic lung diseases. It highlights the use of biomarkers, genetic profiling, phenotyping, and patient-specific data to tailor prevention, diagnosis, and treatment strategies. Sessions will explore targeted therapies, predictive analytics, and individualized care plans that improve treatment effectiveness, reduce adverse effects, and enhance long-term outcomes in diverse patient populations.
COPD Pathophysiology
This track focuses on the underlying biological and physiological mechanisms of Chronic Obstructive Pulmonary Disease (COPD). It explores airway inflammation, oxidative stress, structural lung changes, mucus hypersecretion, and alveolar destruction that contribute to airflow limitation and disease progression. Sessions will also address genetic susceptibility, environmental risk factors such as smoking and air pollution, and the role of immune dysregulation. Understanding COPD pathophysiology is emphasized as a foundation for early diagnosis, targeted therapies, and the development of personalized treatment strategies.
Virtual Respiratory Care
This track explores the use of telemedicine and remote monitoring technologies in respiratory care to improve access, continuity, and outcomes for patients with COPD and other lung diseases. It highlights virtual consultations, home-based monitoring, wearable devices, digital spirometry, and tele-rehabilitation programs that support early detection of exacerbations, treatment adherence, and patient self-management—especially for elderly, rural, and high-risk populations.
Novel COPD Treatments
This track explores emerging and innovative treatment approaches transforming COPD management. It highlights novel pharmacological agents, biologics, regenerative therapies, and anti-inflammatory strategies aimed at slowing disease progression and improving lung function. Sessions will also cover advances in inhaler technologies, combination therapies, and personalized treatment strategies, along with insights from ongoing and upcoming clinical trials shaping the future of COPD care.
Pediatric Respiratory Care
This track focuses on the prevention, diagnosis, and management of respiratory conditions in infants, children, and adolescents. It covers common and chronic pediatric lung disorders such as asthma, bronchitis, pneumonia, cystic fibrosis, and early-life wheezing disorders. Emphasis is placed on early detection, age-appropriate treatment strategies, vaccination, environmental risk reduction, and long-term monitoring to improve respiratory outcomes into adulthood. The track also highlights the role of pediatric nurses, family-centered care, and public health interventions in promoting lifelong lung health.
COPD Immune Responses
This track explores the role of immune and inflammatory mechanisms in the development, progression, and exacerbation of COPD. It focuses on chronic airway inflammation, immune cell dysfunction, cytokine signaling, oxidative stress, and host–pathogen interactions that contribute to lung tissue damage. Sessions will highlight emerging immunomodulatory therapies, biomarkers of inflammation, and personalized approaches targeting immune pathways to improve disease control and patient outcomes.
Ventilatory Support in Lung Care
This track focuses on the essential role of ventilatory support in the management of acute and chronic lung diseases, including COPD, respiratory failure, and critical care conditions. It covers non-invasive and invasive ventilation strategies, oxygen delivery systems, mechanical ventilation protocols, and weaning approaches. Emphasis is placed on optimizing ventilation settings, improving patient comfort, preventing ventilator-associated complications, and enhancing outcomes across hospital, home-care, and emergency settings. The session also highlights advances in ventilatory technologies and the role of multidisciplinary teams in delivering effective respiratory support.
Fibrosis & Chronic Lung Care
This track focuses on the diagnosis, management, and long-term care of pulmonary fibrosis and other chronic lung disorders. It highlights disease mechanisms, early detection strategies, and advances in pharmacological and supportive therapies aimed at slowing disease progression and improving patient outcomes. Sessions will also address symptom management, pulmonary rehabilitation, oxygen therapy, and palliative approaches, with emphasis on multidisciplinary care and enhancing quality of life for patients living with chronic lung diseases.
Asthma–COPD Overlap
This track focuses on the diagnosis and management of Asthma–COPD Overlap, a condition characterized by features of both asthma and chronic obstructive pulmonary disease. It highlights challenges in accurate diagnosis, overlapping inflammatory pathways, and disease phenotyping. Sessions will discuss personalized treatment strategies, including inhaled therapies, biologics, and non-pharmacological interventions. Emphasis is placed on improving symptom control, reducing exacerbations, and enhancing long-term outcomes through integrated and patient-centered care.
Lung Rehabilitation & Lifestyle Care
This track focuses on comprehensive, patient-centered approaches to improving respiratory health and quality of life in individuals with chronic lung diseases. It highlights the role of pulmonary rehabilitation programs that combine supervised exercise training, breathing techniques, education, and psychosocial support to enhance functional capacity and reduce symptom burden. Emphasis is placed on lifestyle modifications such as smoking cessation, nutrition optimization, physical activity, stress management, and adherence to treatment plans. The track also explores community-based rehabilitation, home-based care models, and the integration of multidisciplinary teams to support long-term lung health and prevent disease progression.
COPD Drug Therapy